Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C25H21F2N3O7S2 |
| Molecular Weight | 577.577 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
COC(=O)OCOC1=C2N(C=CC1=O)N([C@@H]3COCCN3C2=O)[C@@H]4C5=C(SCC6=C(F)C(F)=CC=C46)C=CS5
InChI
InChIKey=JFAAVTYPCCKWCW-QUCCMNQESA-N
InChI=1S/C25H21F2N3O7S2/c1-34-25(33)37-12-36-22-16(31)4-6-29-21(22)24(32)28-7-8-35-10-18(28)30(29)20-13-2-3-15(26)19(27)14(13)11-39-17-5-9-38-23(17)20/h2-6,9,18,20H,7-8,10-12H2,1H3/t18-,20+/m1/s1
| Molecular Formula | C25H21F2N3O7S2 |
| Molecular Weight | 577.577 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 2 / 2 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Wed Apr 02 19:13:50 GMT 2025
by
admin
on
Wed Apr 02 19:13:50 GMT 2025
|
| Record UNII |
8P73TA5CLC
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
2417851-93-3
Created by
admin on Wed Apr 02 19:13:50 GMT 2025 , Edited by admin on Wed Apr 02 19:13:50 GMT 2025
|
PRIMARY | |||
|
13345
Created by
admin on Wed Apr 02 19:13:50 GMT 2025 , Edited by admin on Wed Apr 02 19:13:50 GMT 2025
|
PRIMARY | |||
|
8P73TA5CLC
Created by
admin on Wed Apr 02 19:13:50 GMT 2025 , Edited by admin on Wed Apr 02 19:13:50 GMT 2025
|
PRIMARY | |||
|
155280058
Created by
admin on Wed Apr 02 19:13:50 GMT 2025 , Edited by admin on Wed Apr 02 19:13:50 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
antiviral
|